Pharmacokinetics and pharmacodynamics of intranasal and intramuscular administration of naloxone in working dogs administered fentanyl
Abstract Background Working dogs exposed to narcotics might require reversal in the field. Objective To explore the pharmacokinetic and pharmacodynamic effects of naloxone administered intramuscularly (IM) or intranasally (IN) to reverse fentanyl sedation in working dogs. Animals Ten healthy, workin...
| Published in: | Journal of Veterinary Internal Medicine |
|---|---|
| Main Authors: | Ciara A. Barr, Joanne Haughan, Giacomo Gianotti, Kelley Varner, Kenneth J. Drobatz, Darko Stefanovski, Mary Robinson, Mark Pennington, Amanda McGuire, Cynthia M. Otto |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-11-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1111/jvim.16901 |
Similar Items
Nalbuphine Potentiates Reversal of Fentanyl Overdose by Naloxone
by: Mihai Cernea, et al.
Published: (2024-07-01)
by: Mihai Cernea, et al.
Published: (2024-07-01)
Intranasal naloxone to treat suspected synthetic cannabinoid overdose: A case report and literature review
by: Jaden Dickinson, PharmD, BCPP, et al.
Published: (2025-10-01)
by: Jaden Dickinson, PharmD, BCPP, et al.
Published: (2025-10-01)
Systemized approach to equipping medical students with naloxone: a student-driven initiative to combat the opioid crisis
by: Shahin A. Saberi, et al.
Published: (2024-03-01)
by: Shahin A. Saberi, et al.
Published: (2024-03-01)
Naloxone Decriminalization and Opioid Overdose Trends: A Comparative Study of Lucas County, Ohio and the U.S.
by: Margarita Kugotova, et al.
Published: (2025-10-01)
by: Margarita Kugotova, et al.
Published: (2025-10-01)
Superusers experiences in using naloxone to reverse opioid overdose - A qualitative study
by: K. Troberg, et al.
Published: (2022-06-01)
by: K. Troberg, et al.
Published: (2022-06-01)
The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany
by: Simon Fleißner, et al.
Published: (2025-07-01)
by: Simon Fleißner, et al.
Published: (2025-07-01)
Are carfentanil and acrylfentanyl naloxone resistant?
by: Michael G. Feasel, et al.
Published: (2024-02-01)
by: Michael G. Feasel, et al.
Published: (2024-02-01)
Bystander preference for naloxone products: a field experiment
by: Katherine R. Marks, et al.
Published: (2023-11-01)
by: Katherine R. Marks, et al.
Published: (2023-11-01)
Understanding the Impact of Naloxone Distribution in Undeserved Communities
by: Chadwick Huss, et al.
Published: (2024-11-01)
by: Chadwick Huss, et al.
Published: (2024-11-01)
Efficacy of intranasal naloxone compared to other administration routes in prehospital opioid overdose management and beyond: a narrative review
by: Luigi Venuso, et al.
Published: (2025-01-01)
by: Luigi Venuso, et al.
Published: (2025-01-01)
Heroin or fentanyl: Prevalence of confirmed fentanyl in ED patients with suspected heroin overdose
by: Siri Shastry, et al.
Published: (2024-08-01)
by: Siri Shastry, et al.
Published: (2024-08-01)
Examining naloxone access and interest in secondary naloxone distribution on an American Indian Reservation in the Northern Midwest of the United States
by: Kristin E. Schneider, et al.
Published: (2024-12-01)
by: Kristin E. Schneider, et al.
Published: (2024-12-01)
High-dose naloxone formulations are not as essential as we thought
by: Paige M. Lemen, et al.
Published: (2024-05-01)
by: Paige M. Lemen, et al.
Published: (2024-05-01)
Reported outcomes from a community naloxone training and distribution program
by: Kevin Frederiks, et al.
Published: (2025-06-01)
by: Kevin Frederiks, et al.
Published: (2025-06-01)
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky
by: Hannah K. Knudsen, et al.
Published: (2025-03-01)
by: Hannah K. Knudsen, et al.
Published: (2025-03-01)
Equity of overdose education and naloxone distribution provided in the Kentucky HEALing Communities Study
by: Douglas R. Oyler, et al.
Published: (2024-03-01)
by: Douglas R. Oyler, et al.
Published: (2024-03-01)
Increasing access: Making naloxone available at highway rest areas
by: Tim Ingram, et al.
Published: (2025-12-01)
by: Tim Ingram, et al.
Published: (2025-12-01)
A Regional Survey of Attitudes and Experiences in Determining When to Prescribe Intranasal Naloxone for Patients Seen in Palliative Care Clinics in the United States of America
by: Sean Marks, et al.
Published: (2024-10-01)
by: Sean Marks, et al.
Published: (2024-10-01)
A comparison of intramuscular (Zimhi) and intranasal naloxone (Narcan) in reversal of fentanyl-induced apnea: a randomized, crossover, open-label trial
by: Maarten A. van Lemmen, et al.
Published: (2025-05-01)
by: Maarten A. van Lemmen, et al.
Published: (2025-05-01)
Fentanyl Overdose Causes Prolonged Cardiopulmonary Dysregulation in Male SKH1 Mice
by: Mackenzie Newman, et al.
Published: (2024-07-01)
by: Mackenzie Newman, et al.
Published: (2024-07-01)
Design details for overdose education and take‐home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community
by: Kate Sellen, et al.
Published: (2022-10-01)
by: Kate Sellen, et al.
Published: (2022-10-01)
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
by: Zofia Kozak, et al.
Published: (2023-02-01)
by: Zofia Kozak, et al.
Published: (2023-02-01)
Insights from a Pilot Study of Naloxone Education
Published: (2019-12-01)
Published: (2019-12-01)
Community overdose surveillance: Fentanyl involvement in overdose deaths in rural Michigan
by: Grant Victor, et al.
Published: (2023-06-01)
by: Grant Victor, et al.
Published: (2023-06-01)
Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model
by: Hannah K. Knudsen, et al.
Published: (2023-11-01)
by: Hannah K. Knudsen, et al.
Published: (2023-11-01)
Effectiveness of take ACTION online naloxone training for law enforcement officers
by: Chin Hwa Dahlem, et al.
Published: (2023-11-01)
by: Chin Hwa Dahlem, et al.
Published: (2023-11-01)
Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration
by: Margaret Lowenstein, et al.
Published: (2022-08-01)
by: Margaret Lowenstein, et al.
Published: (2022-08-01)
The pharmacokinetics and pharmacodynamics of fentanyl administered via transdermal patch in horses
by: Rachel A. Reed, et al.
Published: (2024-03-01)
by: Rachel A. Reed, et al.
Published: (2024-03-01)
Effectiveness of an Advanced Naloxone Training, Simulation, and Assessment of Second-Year Pharmacy Students
by: Jennifer Courtney, et al.
Published: (2022-11-01)
by: Jennifer Courtney, et al.
Published: (2022-11-01)
Lethal poisoning with theophylline in the form of rectally administered tablets
by: Paweł Kopacz, et al.
Published: (2015-02-01)
by: Paweł Kopacz, et al.
Published: (2015-02-01)
Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review
by: Amina Moustaqim-Barrette, et al.
Published: (2021-03-01)
by: Amina Moustaqim-Barrette, et al.
Published: (2021-03-01)
Naloxone in Buprenorphine Overdose: A Life Saving Intervention
by: Aviral Ratan Srivastava, et al.
Published: (2025-05-01)
by: Aviral Ratan Srivastava, et al.
Published: (2025-05-01)
“I’m not going to lay back and watch somebody die”: a qualitative study of how people who use drugs’ naloxone experiences are shaped by rural risk environment and overdose education/naloxone distribution intervention
by: Zora Kesich, et al.
Published: (2023-11-01)
by: Zora Kesich, et al.
Published: (2023-11-01)
Normalizing fentanyl: interpreting the perceived ‘risk’ of correctional officer work
by: Rosemary Ricciardelli, et al.
Published: (2024-09-01)
by: Rosemary Ricciardelli, et al.
Published: (2024-09-01)
Overdose education and naloxone distribution among women with a history of OUD transitioning to the community following jail release
by: Michele Staton, et al.
Published: (2025-05-01)
by: Michele Staton, et al.
Published: (2025-05-01)
Naloxone dosing by non-medical first-responders at opioid overdoses: findings from a qualitative interview study
by: Joanne Neale, et al.
Published: (2025-04-01)
by: Joanne Neale, et al.
Published: (2025-04-01)
Over the counter naloxone nasal spray: A new hope for opioid crisis management in Pakistan
by: Zmarak Ahmed Khan, et al.
Published: (2025-02-01)
by: Zmarak Ahmed Khan, et al.
Published: (2025-02-01)
Fentanyl: A threat to Brazilian society or an opioid drug of great importance in pain management?
by: Gabriela Pereira Kuhn, et al.
Published: (2025-06-01)
by: Gabriela Pereira Kuhn, et al.
Published: (2025-06-01)
Trends in Opioid Overdose Deaths and Naloxone Distribution from 2019-2022 in Lucas County, Ohio: A Retrospective Study
by: Kelli Curcillo, et al.
Published: (2024-11-01)
by: Kelli Curcillo, et al.
Published: (2024-11-01)
Education Improves Perceived Control but Not Risk Identification in Adolescents Regarding Fentanyl
by: Christine Bakos-Block, et al.
Published: (2025-06-01)
by: Christine Bakos-Block, et al.
Published: (2025-06-01)
Similar Items
-
Nalbuphine Potentiates Reversal of Fentanyl Overdose by Naloxone
by: Mihai Cernea, et al.
Published: (2024-07-01) -
Intranasal naloxone to treat suspected synthetic cannabinoid overdose: A case report and literature review
by: Jaden Dickinson, PharmD, BCPP, et al.
Published: (2025-10-01) -
Systemized approach to equipping medical students with naloxone: a student-driven initiative to combat the opioid crisis
by: Shahin A. Saberi, et al.
Published: (2024-03-01) -
Naloxone Decriminalization and Opioid Overdose Trends: A Comparative Study of Lucas County, Ohio and the U.S.
by: Margarita Kugotova, et al.
Published: (2025-10-01) -
Superusers experiences in using naloxone to reverse opioid overdose - A qualitative study
by: K. Troberg, et al.
Published: (2022-06-01)
